Ben Leach

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Sentinel lymph node surgery may provide a less-invasive alternative to axillary lymph node dissection for nodal staging in node-positive breast cancer.

The FDA has approved cabozantinib, a multi-targeted tyrosine kinase inhibitor, for the treatment of metastatic medullary thyroid cancer.

Tolvaptan, a vasopression V2 receptor antagonist used to increase low levels of sodium in the blood, could be a cost effective way of managing patients who have hyponatremia.

Hyponatremia is associated with longer hospital stays and higher mortality among cancer patients who exhibit the condition.

Cloud-based EMR systems may provide a less expensive alternative to those practices wishing to implement such a system.

Caregivers devoting 20 or more hours per week are looking for their own support and new study shows that much of that support is being provided by technology that allows better communication with physicians and other caregivers.